| Turchia | Austria | Spagna | |
| Ocrevus (ocrelizumab) | da $10,000 | da $35,000 | da $25,000 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi di Ocrevus (ocrelizumab). Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Ocrevus (ocrelizumab) al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Ocrevus (ocrelizumab) e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Ocrevus (ocrelizumab).
Day 1: Arrival
Day 2: Pre-Operation
Day 3: Ocrevus (ocrelizumab) Infusion
Week 1-2: Post-Operation
Week 3-4: Rehabilitation
Please note that each patient"s experience with Ocrevus (ocrelizumab) can differ. Always consult with your healthcare team for personalized advice.
Dr. Solak specializes in treating various cancers, including breast, lung, and gastrointestinal cancers, with extensive training at Hacettepe University Cancer Institute.
Op. Dr. Mustafa Sezer has over 20 years of experience in neurosurgery, specializing in brain and spinal conditions at Private Yüzyıl Hospital.
Dr. Arnon Karni specializes in multiple sclerosis and myasthenia gravis, with immunological studies at Harvard University.
Dr. Topcular specializes in neurology with extensive training at prestigious institutions, including the University of Basel and Istanbul University.
Ocrevus (ocrelizumab) is an innovative drug for the treatment of multiple sclerosis. This is a monoclonal antibody. It is programmed to search for and destroy cells that contribute to the development of multiple sclerosis.
Ocrevus is the first and only drug to date that fights the primary progressive form of multiple sclerosis.
Ocrelizumab reverses the course of the disease and slows its progression. During clinical trials of Ocrevus, doctors recorded a significant decrease in lesions in the brain on MRI images of patients. The drug was approved under an accelerated scheme due to its effectiveness.
Ocrelizumab is often given by injection for the treatment of multiple sclerosis. 1 dose of the drug - 300 mg. At the beginning of treatment, the patient may receive 1 injection, after 2 weeks - another one. Repeated procedures should be carried out every six months.
Today I feel very good. I have been on Ocrevus for about 4 months and the effect is huge. I am delighted! Happy for the people it helps. You know there's a saying, "Don't believe what you hear, believe what you see" - I can lift 25 pounds. I'm stronger, really stronger.
Patient review taken from Youtube